ROIV
ROIV
NASDAQ · Biotechnology

Roivant Sciences Ltd

$36.13
-0.69 (-1.87%)
ROIV vs Biotechnology Average
Profit Margin
ROIV -3,629.2%
Avg -10.1%
Rev Growth
ROIV -48.7%
Avg +16.0%

Biotechnology Peers

1013 stocks in sector
Symbol Name Price Change % Market Cap P/E Margin Growth Div Yield Analyst
ROIV Roivant Sciences Ltd $36.13 -1.87% 28.53B — -3,629.2% -48.7% — Current
ABBV Abbvie Inc $265.12 +0.02% 466.74B 74.0 6.9% +1.8% 4.47% Strong buy Compare
AMGN Amgen Inc $406.04 -0.01% 207.25B 23.7 21.0% +11.8% 3.21% Hold Compare
GILD Gilead Sciences Inc $149.69 -1.11% 187.10B — 28.9% +2.6% 3.98% Strong buy Compare
VRTX Vertex Pharmaceuticals Inc $522.38 +1.17% 130.64B 29.7 32.9% +10.4% — Strong buy Compare
REGN Regeneron Pharmaceuticals $796.02 -0.72% 80.58B 18.6 31.4% +5.6% — Buy Compare
MRNA Moderna Inc $194.82 +6.98% 63.11B — -145.2% -53.4% — Hold Compare
NTRA Natera Inc $408.79 +4.61% 52.80B — -9.0% +41.1% — Strong buy Compare
RVMD Revolution Medicines Inc $199.86 +4.78% 42.21B — 4.4% +0.4% — Strong buy Compare
BIIB Biogen Inc $226.36 -0.51% 32.37B 38.8 13.1% -0.9% — Buy Compare
ALNY Alnylam Pharmaceuticals Inc $249.59 +1.25% 32.33B 40.0 8.5% +53.0% — Strong buy Compare
INSM Insmed Inc $121.55 +2.71% 26.21B — -210.5% +35.2% — Strong buy Compare
INCY Incyte Corp $124.44 -0.16% 25.87B 16.0 25.0% +14.8% — Hold Compare
UTHR United Therapeutics Corp $472.21 -3.52% 21.24B 16.2 41.9% +18.0% — Strong buy Compare
EXAS Exact Sciences Corp $104.91 +0.95% 20.03B — -6.4% +15.9% — Hold Compare
NBIX Neurocrine Biosciences Inc $138.94 -0.39% 15.43B 21.9 16.7% +24.3% — Strong buy Compare
EXEL Exelixis Inc $57.95 +2.15% 14.49B 16.8 33.7% +12.9% — Hold Compare
SMMT Summit Therapeutics Inc $16.38 -0.43% 14.14B — 15.4% -3.6% — Buy Compare
BBIO Bridgebio Pharma Inc $66.28 +0.87% 13.16B — -144.4% +86.3% — Strong buy Compare
HALO Halozyme Therapeutics Inc $115.22 +2.47% 12.70B 30.7 22.7% +28.4% — Strong buy Compare
BMRN Biomarin Pharmaceutical Inc $61.35 -1.38% 12.60B 172.6 10.8% +15.4% — Strong buy Compare